(Q33403870)

26 July 2017

title

Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis (English)

1 reference

Pascaline Boudou-Rouquette

26 July 2017

1 reference

6

Pascaline Boudou-Rouquette

0 references

Géraldine Perkins

Géraldine Perkins

4

0 references

Olivier Mir

Olivier Mir

3

0 references

Romain Coriat

2

Romain Coriat

1 reference

26 July 2017

Marion Dhooge

1

1 reference

26 July 2017

Catherine Brezault

5

1 reference

26 July 2017

Pascaline Boudou-Rouquette

6

1 reference

26 July 2017

François Goldwasser

7

1 reference

26 July 2017

Stanislas Chaussade

8

1 reference

26 July 2017

publication date

16 October 2012

1 reference

26 July 2017

1 reference

26 July 2017

volume

84

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

32-38

1 reference

Sorafenib in advanced hepatocellular carcinoma

26 July 2017

cites work

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib

21 January 2018

1 reference

Combination of topotecan and oxaliplatin in inoperable hepatocellular cancer patients

21 January 2018

1 reference

Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients.

21 January 2018

1 reference

Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study

21 January 2018

1 reference

Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules

21 January 2018

1 reference

Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma

21 January 2018

1 reference

Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines.

21 January 2018

1 reference

Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities

21 January 2018

1 reference

Medical treatments for hepatocellular carcinoma (HCC): what's next?

21 January 2018

1 reference

Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations

21 January 2018

1 reference

Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate

21 January 2018

1 reference

Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment

21 January 2018

1 reference

An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity.

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

21 January 2018

1 reference

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study

21 January 2018

1 reference

Assessing the quality of initial consultations regarding adjuvant colon cancer therapy

21 January 2018

1 reference

The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib

21 January 2018

1 reference

Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma

21 January 2018

1 reference

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000342763

1 reference

26 July 2017

1 reference